These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10684709)

  • 1. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer.
    Mariani A; Webb MJ; Galli L; Podratz KC
    Gynecol Oncol; 2000 Mar; 76(3):348-56. PubMed ID: 10684709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
    Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
    Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
    Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
    Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
    J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Aug; 102(2):214-7. PubMed ID: 16457876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.
    Chan JK; Cheung MK; Huh WK; Osann K; Husain A; Teng NN; Kapp DS
    Cancer; 2006 Oct; 107(8):1823-30. PubMed ID: 16977653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
    Kikuchi A; Yanase T; Sasagawa M; Honma S
    J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer.
    Mariani A; Webb MJ; Rao SK; Lesnick TG; Podratz KC
    Gynecol Oncol; 2001 Feb; 80(2):113-20. PubMed ID: 11161847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
    Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium.
    Larson DM; Johnson KK
    Gynecol Oncol; 1993 Dec; 51(3):345-8. PubMed ID: 8112643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM; Johnson KK; Reyes CN; Broste SK
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.